Inventiva (IVA) Assets Average (2019 - 2025)
Inventiva (IVA) posted quarterly Assets Average of $246.5 million for Q4 2025, up 233.48% year-over-year from $73.9 million in Q4 2024, and up 49.53% quarter-over-quarter from $164.8 million in Q2 2025.
Analysis
Inventiva (IVA) Assets Average (2019 - 2025) Analysis & Trends
Inventiva's Assets Average history runs 7 years deep, the most recent figure standing at $246.5 million for Q4 2025.
- In Q4 2025, Assets Average rose 233.48% year-over-year to $246.5 million; the TTM figure through Dec 2025 stood at $246.5 million (up 233.48% YoY), while the FY2025 annual figure was $208.8 million, up 106.75% from the prior year.
- Assets Average for Q4 2025 stood at $246.5 million, up from $164.8 million in the prior quarter.
- The five-year high for Assets Average was $246.5 million in Q4 2025, with the low at $47.8 million in Q2 2024.
- The 5-year median for Assets Average is $97.7 million (2023), against an average of $115.0 million.
- The sharpest annual moves came in 2022 and 2025: Assets Average plunged 53.55% in 2022, then jumped 245.03% in 2025.
- Inventiva's Assets Average stood at $140.4 million in 2021, then slumped by 50.25% to $69.8 million in 2022, then dropped by 21.38% to $54.9 million in 2023, then soared by 34.64% to $73.9 million in 2024, then soared by 233.48% to $246.5 million in 2025.
- Business Quant data shows IVA's Assets Average at $246.5 million in Q4 2025, $164.8 million in Q2 2025, and $73.9 million in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.22 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 3.29 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.86 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 5.34 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.82 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | 246.51 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 246.51 Mn |
| Jun 30, 2025 | 164.85 Mn |
| Dec 31, 2024 | 73.92 Mn |
| Jun 30, 2024 | 47.78 Mn |
| Dec 31, 2023 | 75.98 Mn |
| Jun 30, 2023 | 97.73 Mn |
| Jun 30, 2022 | 127.60 Mn |
| Dec 31, 2021 | 140.35 Mn |
| Jun 30, 2021 | 150.32 Mn |
| Mar 31, 2021 | 162.56 Mn |
| Dec 31, 2020 | 120.66 Mn |
| Dec 31, 2019 | 77.07 Mn |